Jeanette E Boudreau
Overview
Explore the profile of Jeanette E Boudreau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
1235
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kelly B, Boudreau J, Beyea S, Brewer K
Npj Imaging
. 2025 Jan;
3(1):3.
PMID: 39872292
Molecular imaging is used in clinical and research settings. Since tools to study viral pathogenesis longitudinally and systemically are limited, molecular imaging is an attractive and largely unexplored tool. This...
2.
Boudreau J
J Clin Invest
. 2024 Dec;
134(24).
PMID: 39680458
The approach and efficacy of treatments for high-grade serous carcinoma (HGSC) of the ovary have changed little in decades. Although numerous studies demonstrated immune infiltration as frequent and prognostically beneficial,...
3.
Westhaver L, Nersesian S, Arseneau R, Hefler J, Hargreaves B, Edgar A, et al.
Heliyon
. 2024 Mar;
10(5):e27122.
PMID: 38463874
normothermic machine perfusion (NMP) preserves donor organs and permits real-time assessment of allograft health, but the most effective indicators of graft viability are uncertain. Mitochondrial DNA (mtDNA), released consequent to...
4.
Nersesian S, Arseneau R, Mejia J, Lee S, Westhaver L, Griffiths N, et al.
Front Immunol
. 2024 Feb;
14:1307873.
PMID: 38318505
Background: For patients with high grade serous carcinoma of the ovary (HGSC), survival rates have remained static for the last half century. Despite the presence of tumor mutations and infiltration...
5.
Nersesian S, Carter E, Lee S, Westhaver L, Boudreau J
Front Immunol
. 2023 Dec;
14:1269614.
PMID: 38090565
Natural killer (NK) cells integrate heterogeneous signals for activation and inhibition using germline-encoded receptors. These receptors are stochastically co-expressed, and their concurrent engagement and signaling can adjust the sensitivity of...
6.
Lee S, Hoskin V, Laumont C, Snelling S, Lindo L, Bird L, et al.
Biochem Cell Biol
. 2023 Oct;
102(1):1-8.
PMID: 37870124
From 19 to 21 November 2022, BioCanRx held its first post-pandemic in-person Summit for Cancer Immunotherapy in Montreal, Canada. The meeting was well attended by patients, trainees, researchers, clinicians, and...
7.
Shin E, Westhaver L, Nersesian S, Boudreau J, Gala-Lopez B
Transplant Proc
. 2023 Mar;
55(3):586-596.
PMID: 36973148
Background: Predicting complications after liver transplantation (LT) remains challenging. We propose incorporating the De Ritis ratio (DRR), a widely known parameter of liver dysfunction, into current or future scoring models...
8.
Azizieh Y, Westhaver L, Badrudin D, Boudreau J, Gala-Lopez B
Front Med Technol
. 2023 Mar;
5:1079003.
PMID: 36908294
Liver transplantation is a well-established treatment for many with end-stage liver disease. Unfortunately, the increasing organ demand has surpassed the donor supply, and approximately 30% of patients die while waiting...
9.
Mansouri S, Daniel L, Amhis N, Leveille M, Boudreau J, Alkayyal A, et al.
Front Oncol
. 2023 Mar;
13:1071751.
PMID: 36874130
Pancreatic ductal adenocarcinoma (PDAC) is a high fatality cancer with one of the worst prognoses in solid tumors. Most patients present with late stage, metastatic disease and are not eligible...
10.
Carter E, Pugh-Toole M, Kabil A, Boudreau J, Nersesian S
J Leukoc Biol
. 2023 Feb;
114(1):79-83.
PMID: 36805942
The Canadian Society for Immunology 2022 Annual Meeting (June 17-20, 2022) brought together immunologists from across the country to discuss current topics and cutting-edge research in immunology. Here we highlight...